Q&A Session - Telehealth for Opioid Use Disorder during the COVID-19 Pandemic and Beyond
This is the Q&A session for the third webinar in the telehealth series for the Opioid Response Network (ORN).
There have been significant telehealth legal, regulatory, and reimbursement changes at the federal and state level in the context of the COVID-19 pandemic. These changes have allowed for a rapid expansion of telehealth nationally, including for the assessment and treatment of mental health and substance use disorders.
This webinar, hosted by the American Osteopathic Academy of Addiction Medicine through a Opioid Response Network STR-TA grant, will cover the telehealth legal, regulatory, clinical, and reimbursement landscape prior to and during the pandemic. The webinar will focus on telehealth for the treatment of opioid use disorder and will include an overview of key laws and regulations including the Ryan Haight Act, the Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, and relevant changes made during the national public health emergency (PHE). The webinar will include a discussion of what the future telehealth landscape may look like once the national PHE and state-by-state executive orders and emergency declarations are lifted.
Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Shabana Khan, MD
Shabana Khan, MD has a decade of experience in telemedicine. She is an Assistant Professor and the Director of Telepsychiatry for the Department of Child and Adolescent Psychiatry at NYU Langone Health in New York City.
She is Co-Chair of the American Academy of Child and Adolescent Psychiatry (AACAP) Telepsychiatry Committee, Chair of the NYU Grossman School of Medicine Telemedicine Taskforce, and member of the American Psychiatric Association (APA) Telepsychiatry Committee.
Dr. Khan is an expert in undergraduate and graduate medical education and training in telemedicine.
Through her active involvement and collaboration with the American Telemedicine Association (ATA), APA, AACAP, and Center for Telehealth and e-Health Law (CTeL), Dr. Khan has helped inform telemedicine legislation, policy, and regulations at the federal and state level.
Dr. Khan received a B.A. in Neuroscience from Barnard College and an M.D. from SUNY Downstate College of Medicine. She completed general adult psychiatry residency and child and adolescent psychiatry fellowship at Western Psychiatric Hospital of the University of Pittsburgh Medical Center (UPMC). She is board-certified in General Psychiatry and Child and Adolescent Psychiatry.
Julie Kmiec, DO, FAOAAM (Moderator)
Julie Kmiec, DO, graduated from Western University of Health Sciences College of Osteopathic Medicine of the Pacific. She completed her general psychiatry residency training and addiction psychiatry fellowship at Western Psychiatric Institute and Clinic (WPIC) in Pittsburgh, PA. She is currently an Assistant Professor of Psychiatry at the University of Pittsburgh School of Medicine. She is board certified in general and addiction psychiatry. Dr. Kmiec is the Medical Director of the Ambulatory Detoxification Program, Bridge Clinic, and is the founding medical director of the Narcotic Addiction Treatment Program’s Buprenorphine Clinic at WPIC. Her clinical interests include treatment of drug and alcohol withdrawal, prevention of overdose, and pharmacotherapy for the treatment of addictions. Dr. Kmiec’s research involves training healthcare professionals on the implementation of medications for opioid use disorder. She is the President of the American Osteopathic Academy of Addiction Medicine.